Zevra Therapeutics, Inc. (ZVRA)
NASDAQ · Healthcare
Zevra Therapeutics, Inc. Operating Income 2013–2025
Zevra Therapeutics, Inc. annual/quarterly operating income history and growth rate from 2013 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Zevra Therapeutics, Inc. operating income for the quarter ending March 31, 2026 was 52.1 M, a 1072.51% decrease year-over-year.
- Zevra Therapeutics, Inc. operating income for the twelve months ending March 31, 2026 was -20.1 M, a 76.87% decrease year-over-year.
- Zevra Therapeutics, Inc. annual operating income for 2025 was -62.9 M, a 27.65% decrease from 2024.
- Zevra Therapeutics, Inc. annual operating income for 2024 was -87.0 M, a 75.40% increase from 2023.
- Zevra Therapeutics, Inc. annual operating income for 2023 was -49.6 M, a 16.54% increase from 2022.
- Zevra Therapeutics, Inc. annual operating income for 2022 was -42.6 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Zevra Therapeutics, Inc. Operating Income — FAQ
Zevra Therapeutics, Inc. (ZVRA) operating income over the last 11 years — annual and quarterly figures with year-over-year growth and charts.
What is Zevra Therapeutics, Inc.'s operating income?
Zevra Therapeutics, Inc. (ZVRA) reported operating income of -$63M for fiscal 2025.
Where can I see ZVRA's operating income history?
The chart and table above show Zevra Therapeutics, Inc.'s operating income by year and by quarter, including the growth rate.